{"id":"W2063123552","doi":"10.1002/cncr.22036","title":"Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer","year":2006,"lang":"en","type":"article","venue":"Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Erlotinib; Cetuximab; Gemcitabine; Bevacizumab; Oncology; Pancreatic cancer; Clinical trial; Oxaliplatin; Capecitabine; Internal medicine; Cancer; Progression-free survival; Targeted therapy; Colorectal cancer; Epidermal growth factor receptor; Overall survival; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002577559,0.00009458669,0.0003996888,0.00004340645,0.00002283877,0.000001673587,0.0001229061,0.00005938188,0.0001891511],"category_scores_gemma":[0.00006372813,0.00006169453,0.0001053011,0.0001666279,0.0004887775,0.00001098827,0.00003530746,0.0002169529,9.804799e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004699307,"about_ca_system_score_gemma":0.001346984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007169324,"about_ca_topic_score_gemma":0.0002890546,"domain_scores_codex":[0.9988763,0.00004605799,0.00040064,0.0001790314,0.0003002532,0.0001976968],"domain_scores_gemma":[0.9990383,0.0002043467,0.0002699993,0.0002166442,0.0002381465,0.00003254561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005987533,0.0002829404,0.982442,0.00009558111,0.00008677165,0.00005789258,0.0000962545,0.00007294957,0.007883588,0.000184411,0.0022626,0.005936265],"study_design_scores_gemma":[0.002430378,0.0003770341,0.9877559,0.0007695114,0.0001032505,0.0002542117,0.0001537173,0.001166215,0.003796545,0.0002034959,0.002931435,0.0000582901],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984373,0.001396247,0.00001479711,0.007381495,0.0001517938,0.0004472952,0.00001880607,0.000008083058,0.006208538],"genre_scores_gemma":[0.9953548,0.0001414745,0.001538137,0.0003060643,0.0001141331,0.0002041302,0.000005274022,0.00001036385,0.002325634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01098184,"threshold_uncertainty_score":0.251583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04230732459078521,"score_gpt":0.3999102647213624,"score_spread":0.3576029401305773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}